Skip to main content
TMO
NYSE Industrial Applications And Services

Thermo Fisher Completes $8.875 Billion Acquisition of Clario Holdings

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$478.4
Mkt Cap
$177.614B
52W Low
$385.46
52W High
$643.99
52W Position info
24% above low
Off High info
26% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

TMO sits 24% above its 52-week low of $385.46.

Summary

Thermo Fisher Scientific has completed its $8.875 billion acquisition of Clario Holdings, Inc., a strategic move expected to enhance its clinical research offerings and be accretive to earnings.


Key Events · M&A and Partnerships · TMO

  • Acquisition Finalized

    Thermo Fisher Scientific completed the acquisition of Clario Holdings, Inc. for $8.875 billion in cash, plus potential earn-out payments of up to $525 million.

  • Strategic Expansion

    The acquisition strengthens Thermo Fisher's position in clinical research by adding Clario's industry-leading endpoint data solutions, enhancing drug development capabilities.

  • Financial Impact

    The deal is expected to be accretive to adjusted EPS by $0.45 in the first year and generate approximately $175 million in adjusted operating income from synergies by year five.


Analysis · TMO · Industrial Applications And Services

This 8-K announces the completion of Thermo Fisher Scientific's previously disclosed acquisition of Clario Holdings, Inc. for $8.875 billion in cash, with potential additional earn-out payments. The acquisition, which represents a significant strategic expansion, strengthens the company's position in clinical research by integrating Clario's endpoint data solutions. Management expects the deal to be accretive to adjusted EPS by $0.45 in the first year and generate $175 million in adjusted operating income from synergies by year five, primarily from revenue synergies. This finalizes a major strategic move that was initially announced as pending in the company's 10-K on February 26, 2026.

How filings like this one have moved

In the 30 days to Nov 8, 2026, 46.9% of the 1569 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.35%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, TMO was trading at $478.40 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $177.6B. The 52-week trading range was $385.46 to $643.99. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

TMO - Latest Insights

TMO
Nov 06, 2026, 10:21 AM EST
Source: Benzinga
Importance Score:
7
Price at Filing: $686.10
Real-time Price: $694.76 info
Change: +$8.66 (+1%) info
Market Cap: $257.42B info
TMO
Oct 30, 2026, 10:52 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $699.82
Real-time Price: $694.76 info
Change: -$5.06 (-0.72%) info
Market Cap: $257.42B info
TMO
Oct 21, 2026, 2:31 PM EDT
Source: Benzinga
Importance Score:
7
Price at Filing: $696.57
Real-time Price: $694.76 info
Change: -$1.81 (-0.26%) info
Market Cap: $257.42B info
TMO
Oct 21, 2026, 6:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $690.00
Real-time Price: $694.76 info
Change: +$4.76 (+0.69%) info
Market Cap: $257.42B info
TMO
Jul 31, 2026, 10:51 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $564.80
Real-time Price: $694.76 info
Change: +$129.96 (+23%) info
Market Cap: $257.42B info